{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T17:00:16Z","timestamp":1777309216857,"version":"3.51.4"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T00:00:00Z","timestamp":1707264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>The post-COVID-19 condition (PCC) is characterized by debilitating persistent symptoms, including symptoms suggesting neurological aberrations such as concentration difficulties, impaired memory, pain, and sleep disturbances. The underlying mechanisms remain elusive. This study aimed to investigate brain injury biomarkers, neurocognitive test performance, and self-reported neurological and neuropsychological symptoms in young people with PCC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 404 non-hospitalized adolescents and young adults aged 12\u201325\u2009years who tested positive for SARS-CoV-2, along with 105 matched SARS-CoV-2 negative individuals, were prospectively enrolled and followed-up for 6 months (Clinical Trials ID: NCT04686734). All participants underwent comprehensive assessment encompassing clinical examinations, questionnaires, neurocognitive testing and blood sampling. Serum samples were immunoassayed for the brain injury biomarkers neurofilament light chain (Nfl) and glial fibrillary acidic protein (GFAp). At 6\u2009months, cross-sectional analyses of serum Nfl\/GFAp, neurocognitive test results and symptom scores were performed across groups based on adherence to PCC criteria as well as initial SARS-CoV-2 test results. Also, associations between Nfl\/GFAp, neurocognitive test results, and symptom scores were explored.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 381 SARS-CoV-2 positive and 85 SARS-CoV-2 negative were included in the final analysis at 6\u2009months, of whom 48% and 47%, respectively, adhered to the PCC criteria. Serum levels of Nfl and GFAp were almost equal across groups and did not differ from reference values in healthy populations. Also, neurocognitive test results were not different across groups, whereas symptom scores were significantly higher in patients fulfilling PCC criteria (independent of initial SARS-CoV-2 status). No significant associations between Nfl\/GFAp, neurocognitive test results, and symptom scores were found.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Normal brain injury biomarkers and neurocognitive performance 6\u2009months after mild COVID-19 implies that the persistent symptoms associated with PCC are not concurrent with ongoing central nervous system damage or permanent disruption of cognitive functions. This finding contradicts the notion of neuroinflammation as a likely explanation for the persistent symptoms.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2024.1345787","type":"journal-article","created":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T05:34:36Z","timestamp":1707284076000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Neurological involvement among non-hospitalized adolescents and young adults 6\u2009months after acute COVID-19"],"prefix":"10.3389","volume":"15","author":[{"given":"Lise Beier","family":"Havdal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Selvakumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lise","family":"Lund Berven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tonje","family":"Stiansen-Sonerud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trygve","family":"Holm\u00f8y","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vegard Bruun Bratholm","family":"Wyller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,2,7]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S0140-6736(20)32656-8","article-title":"6-month consequences of COVID-19 in patients discharged from hospital: a cohort study","volume":"397","author":"Huang","year":"2021","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S0140-6736(21)01755-4","article-title":"1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study","volume":"398","author":"Huang","year":"2021","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41586-021-03553-9","article-title":"High-dimensional characterization of post-acute sequelae of COVID-19","volume":"594","author":"Al-Aly","year":"2021","journal-title":"Nature"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e210830","DOI":"10.1001\/jamanetworkopen.2021.0830","article-title":"Sequelae in adults at 6 months after COVID-19 infection","volume":"4","author":"Logue","year":"2021","journal-title":"JAMA Netw Open"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"104245","DOI":"10.1016\/j.ebiom.2022.104245","article-title":"Long COVID symptoms in exposed and infected children, adolescents and their parents one year after SARS-CoV-2 infection: a prospective observational cohort study","volume":"84","author":"Haddad","year":"2022","journal-title":"EBioMedicine"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"120162","DOI":"10.1016\/j.jns.2022.120162","article-title":"Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis","volume":"434","author":"Premraj","year":"2022","journal-title":"J Neurol Sci"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/S2352-4642(21)00198-X","article-title":"Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2","volume":"5","author":"Molteni","year":"2021","journal-title":"Lancet Child Adolesc Health"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.jiph.2022.06.013","article-title":"Persistent neurological manifestations in long COVID-19 syndrome: a systematic review and meta-analysis","volume":"15","author":"Pinzon","year":"2022","journal-title":"J Infect Public Health"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1016\/S1473-3099(21)00703-9","article-title":"A clinical case definition of post-COVID-19 condition by a Delphi consensus","volume":"22","author":"Soriano","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3390\/medicina57050418","article-title":"Long COVID and Myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS)\u2014a systemic review and comparison of clinical presentation and symptomatology","volume":"57","author":"Wong","year":"2021","journal-title":"Medicina"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"915712","DOI":"10.3389\/fneur.2022.915712","article-title":"Neurological involvement in COVID-19 among non-hospitalized adolescents and young adults","volume":"13","author":"Havdal","year":"2022","journal-title":"Front Neurol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.1111\/ene.14703","article-title":"Biomarkers for central nervous system injury in cerebrospinal fluid are elevated in COVID-19 and associated with neurological symptoms and disease severity","volume":"28","author":"Virhammar","year":"2021","journal-title":"Eur J Neurol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e1754","DOI":"10.1212\/WNL.0000000000010111","article-title":"Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19","volume":"95","author":"Kanberg","year":"2020","journal-title":"Neurology"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.bbi.2020.12.022","article-title":"High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms","volume":"93","author":"Franke","year":"2021","journal-title":"Brain Behav Immun"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41582-020-00453-w","article-title":"Neurological infection with SARS-CoV-2 \u2014 the story so far","volume":"17","author":"Solomon","year":"2021","journal-title":"Nat Rev Neurol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e1151","DOI":"10.1212\/NXI.0000000000001151","article-title":"Plasma biomarkers of Neuropathogenesis in hospitalized patients with COVID-19 and those with Postacute sequelae of SARS-CoV-2 infection","volume":"9","author":"Hanson","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.tins.2021.10.006","article-title":"SARS-CoV-2-specific neuropathology: fact or fiction?","volume":"44","author":"Pr\u00f6bstel","year":"2021","journal-title":"Trends Neurosci"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.neubiorev.2017.01.015","article-title":"Symptoms and the body: taking the inferential leap","volume":"74","author":"Van den Bergh","year":"2017","journal-title":"Neurosci Biobehav Rev"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nrn3950","article-title":"Interoceptive predictions in the brain","volume":"16","author":"Barrett","year":"2015","journal-title":"Nat Rev Neurosci"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e235763","DOI":"10.1001\/jamanetworkopen.2023.5763","article-title":"Prevalence and characteristics associated with post-COVID-19 condition among nonhospitalized adolescents and young adults","volume":"6","author":"Selvakumar","year":"2023","journal-title":"JAMA Netw Open"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1001\/jamapsychiatry.2022.2640","article-title":"Associations of depression, anxiety, worry, perceived stress, and loneliness prior to infection with risk of post\u2013COVID-19 conditions","volume":"79","author":"Wang","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41582-019-0265-2","article-title":"Neurofilament light chain \u2014 new potential for prediction and prognosis","volume":"15","author":"Fyfe","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/mds.28101","article-title":"Is there a value of Neurofilament light as a biomarker for neurodegeneration in Parkinson's disease?","volume":"35","author":"Zetterberg","year":"2020","journal-title":"Mov Disord"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1093\/brain\/awac328","article-title":"The multifaceted role of neurofilament light chain protein in non-primary neurological diseases","volume":"146","author":"Abu-Rumeileh","year":"2023","journal-title":"Brain"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.4155\/bio-2019-0163","article-title":"Establishment of neurofilament light chain Simoa assay in cerebrospinal fluid and blood","volume":"11","author":"Hendricks","year":"2019","journal-title":"Bioanalysis"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"4560","DOI":"10.2174\/1381612825666191210154535","article-title":"Neurofilament proteins as prognostic biomarkers in neurological disorders","volume":"25","author":"Lee","year":"2020","journal-title":"Curr Pharm Des"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1136\/jim-2020-001432","article-title":"Discriminative value of glial fibrillar acidic protein (GFAP) as a diagnostic tool in acute stroke. Individual patient data meta-analysis","volume":"68","author":"Cabezas","year":"2020","journal-title":"J Investig Med"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"fcaa137","DOI":"10.1093\/braincomms\/fcaa137","article-title":"Plasma glial fibrillary acidic protein and neurofilament light chain, but not tau, are biomarkers of sports-related mild traumatic brain injury","volume":"2","author":"Laverse","year":"2020","journal-title":"Brain Commun"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"e1299","DOI":"10.1212\/WNL.0000000000008160","article-title":"Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD","volume":"93","author":"Watanabe","year":"2019","journal-title":"Neurology"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41582-021-00616-3","article-title":"Blood GFAP as an emerging biomarker in brain and spinal cord disorders","volume":"18","author":"Abdelhak","year":"2022","journal-title":"Nat Rev Neurol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1002\/ana.26004","article-title":"Serum Neurofilament light chain levels in the intensive care unit: comparison between severely ill patients with and without coronavirus disease 2019","volume":"89","author":"Sutter","year":"2021","journal-title":"Ann Neurol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1007\/s00415-021-10517-6","article-title":"Blood neurofilament light concentration at admittance: a potential prognostic marker in COVID-19","volume":"268","author":"Aamodt","year":"2021","journal-title":"J Neurol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"120324","DOI":"10.1016\/j.jns.2022.120324","article-title":"Plasma biomarkers of brain injury in COVID-19 patients with neurological symptoms","volume":"439","author":"Sahin","year":"2022","journal-title":"J Neurol Sci"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1007\/s00415-023-11768-1","article-title":"Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual participant data meta-analysis","volume":"270","author":"Abdelhak","year":"2023","journal-title":"J Neurol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1089\/neur.2023.0014","article-title":"Plasma UCHL1, GFAP, tau, and NfL are not different in young healthy persons with mild COVID-19 symptoms early in the pandemic: a pilot study","volume":"4","author":"Rogatzki","year":"2023","journal-title":"Neurotrauma Rep"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.3390\/diagnostics13132167","article-title":"Concentrations of serum brain injury biomarkers following SARS-CoV-2 infection in individuals with and without long-COVID-results from the prospective population-based COVI-GAPP study","volume":"13","author":"Telser","year":"2023","journal-title":"Diagnostics"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/978-0-387-79061-9_3066","article-title":"Wechsler intelligence scale for children","volume-title":"Encyclopedia of Child Behavior and Development","author":"Grizzle","year":"2011"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1076\/clin.12.1.43.1726","article-title":"Hopkins verbal learning test \u2013 revised: normative data and analysis of inter-form and test-retest reliability","volume":"12","author":"Benedict","year":"2010","journal-title":"Clin Neuropsychol"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S0885-3924(02)00526-2","article-title":"The Norwegian brief pain inventory questionnaire","volume":"24","author":"Klepstad","year":"2002","journal-title":"J Pain Symptom Manag"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1080\/07420520802110613","article-title":"Accounting for partial sleep deprivation and cumulative sleepiness in the three-process model of alertness regulation","volume":"25","author":"\u00c5kerstedt","year":"2009","journal-title":"Chronobiol Int"},{"key":"ref41","volume-title":"Norwegian immunisation registry SYSVAK","year":""},{"key":"ref42","doi-asserted-by":"publisher","first-page":"953","DOI":"10.7326\/0003-4819-121-12-199412150-00009","article-title":"The chronic fatigue syndrome: a comprehensive approach to its definition and study. International chronic fatigue syndrome study group","volume":"121","author":"Fukuda","year":"1994","journal-title":"Ann Intern Med"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"103512","DOI":"10.1016\/j.ebiom.2021.103512","article-title":"Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up","volume":"70","author":"Kanberg","year":"2021","journal-title":"EBioMedicine"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1233192","DOI":"10.3389\/fneur.2023.1233192","article-title":"Neurological manifestations of post-acute sequelae of COVID-19: which liquid biomarker should we use?","volume":"14","author":"Comeau","year":"2023","journal-title":"Front Neurol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"13144","DOI":"10.1038\/s41598-023-39698-y","article-title":"Central nervous system biomarkers GFAp and NfL associate with post-acute cognitive impairment and fatigue following critical COVID-19","volume":"13","author":"Bark","year":"2023","journal-title":"Sci Rep"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s42466-022-00217-5","article-title":"No serological evidence for neuronal damage or reactive gliosis in neuro-COVID-19 patients with long-term persistent headache","volume":"4","author":"de Boni","year":"2022","journal-title":"Neurol Res Pract"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.3390\/ijms24032715","article-title":"Transient changes in the plasma of astrocytic and neuronal injury biomarkers in COVID-19 patients without neurological syndromes","volume":"24","author":"Lennol","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"e2342741","DOI":"10.1001\/jamanetworkopen.2023.42741","article-title":"Self-reported neuropsychiatric post\u2013COVID-19 condition and CSF markers of Neuroinflammation","volume":"6","author":"Farhadian","year":"2023","journal-title":"JAMA Netw Open"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"e2118717","DOI":"10.1001\/jamanetworkopen.2021.18717","article-title":"Self-reported memory problems 8 months after COVID-19 infection","volume":"4","author":"S\u00f8raas","year":"2021","journal-title":"JAMA Netw Open"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ijid.2022.11.009","article-title":"Post-acute symptoms 3-15 months after COVID-19 among unvaccinated and vaccinated individuals with a breakthrough infection","volume":"126","author":"Brunvoll","year":"2023","journal-title":"Int J Infect Dis"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"111063","DOI":"10.1016\/j.jpsychores.2022.111063","article-title":"Subjective and objective cognitive function in adolescent with chronic fatigue following Epstein-Barr virus infection","volume":"163","author":"\u00d8ie","year":"2022","journal-title":"J Psychosom Res"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"935442","DOI":"10.3389\/fneur.2022.935442","article-title":"Predictors of chronic fatigue syndrome and mood disturbance after acute infection","volume":"13","author":"Sandler","year":"2022","journal-title":"Front Neurol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.cell.2022.01.014","article-title":"Multiple early factors anticipate post-acute COVID-19 sequelae","volume":"185","author":"Su","year":"2022","journal-title":"Cell"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1016\/j.neuron.2022.10.006","article-title":"The neurobiology of long COVID","volume":"110","author":"Monje","year":"2022","journal-title":"Neuron"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"4097","DOI":"10.1093\/brain\/awac321","article-title":"Brain injury in COVID-19 is associated with dysregulated innate and adaptive immune responses","volume":"145","author":"Needham","year":"2022","journal-title":"Brain"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"641","DOI":"10.2174\/1567205019666220908084559","article-title":"Cytokine storm and neuropathological alterations in patients with neurological manifestations of COVID-19","volume":"19","author":"Tsagkaris","year":"2022","journal-title":"Curr Alzheimer Res"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"4436","DOI":"10.1007\/s00415-021-10595-6","article-title":"Blood neurofilament light chain and total tau levels at admission predict death in COVID-19 patients","volume":"268","author":"De Lorenzo","year":"2021","journal-title":"J Neurol"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"1081718","DOI":"10.3389\/fimmu.2022.1081718","article-title":"Inflammatory markers and pulmonary function in adolescents and young adults 6 months after mild COVID-19","volume":"13","author":"Sommen","year":"2022","journal-title":"Front Immunol"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1016\/S2213-2600(22)00501-X","article-title":"A new paradigm is needed to explain long COVID","volume":"11","author":"Saunders","year":"2023","journal-title":"Lancet Respir Med"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1136\/bmj.38933.585764.AE","article-title":"Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study","volume":"333","author":"Hickie","year":"2006","journal-title":"BMJ"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1345787\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,7]],"date-time":"2024-02-07T05:34:40Z","timestamp":1707284080000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2024.1345787\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,7]]},"references-count":60,"alternative-id":["10.3389\/fneur.2024.1345787"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2024.1345787","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,7]]},"article-number":"1345787"}}